Wednesday, 22 October 2008 15:00–16:00
PLENARY SESSION 2
Proffered paper session
34 ORAL Advantages of a modified continual reassessment method (CRM) for dose finding studies: experience in ongoing phase I trials with ABT-263

https://doi.org/10.1016/S1359-6349(08)71966-9Get rights and content

References (0)

Cited by (0)

View full text